Biotech&Pharma Archives - CIG News

Browse By

Category Archives: Biotech&Pharma

[Biotech&Pharma] I-Mab IPO: What You Need to Know

The 2-year lull in the U.S. listing of Chinese biotechs is expected to end this week, with the upcoming IPO of I-Mab. The IPO Terms Shanghai-based I-Mab, a clinical-stage biopharma company, has filed to offer 7.41 million ADSs representing 17.04 million ordinary shares in an

[Biotech&Pharma] CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer

VANCOUVER, Washington, Jan. 13, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the Company has filed for Breakthrough Therapy designation